Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway

被引:17
作者
Aase, Audun
Herstad, Tove Karin
Merino, Samuel
Brandsdal, Kari Torkildsen
Berdal, Bjorn Peter
Aleksandersen, Erja M.
Aaberge, Ingeborg S.
机构
[1] Norwegian Inst Publ Hlth, Dept Bacteriol & Immunol, Oslo, Norway
[2] Armed Forces Med Serv, Gen Practice Branch, Oslo, Norway
[3] Inst Microbiol, Armed Forces Med Serv, Oslo, Norway
[4] Ullevaal Univ Hosp, Oslo, Norway
关键词
D O I
10.1128/CVI.00081-07
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bordetella pertussis is the causative agent of pertussis (whooping cough). Despite high vaccination coverage, pertussis remains a significant disease in many countries. Besides vaccination, transient carriage of Bordetella spp. or other cross-reacting (organisms adds to the immunity against pertussis. However, the various immunological mechanisms conferring protection remain largely unknown. In this study, paired serum samples from 464 healthy Norwegian military recruits were collected, the first at enrolment and the second about 8 months later. The prevalence of pertussis during military service was examined by comparing the paired serum samples for immunoglobulin G (IgG) antibodies against pertussis toxin (PT) by enzyme-linked immunosorbent assay (ELISA). Seventy-eight percent of the recruits had low levels of IgG antibodies against PT in both samples. Conversely, 8.4% of the recruits demonstrated high anti-PT IgG levels in the first sample, indicative of recent pertussis prior to enrolment. One recruit experienced seroconversion, indicating pertussis during service. A subset of 248 serum samples with low, medium, and high anti-PT IgG titers were analyzed by a different ELISA kit for IgG and IgA antibodies against PT and filamentous hemagglutinin (FHA) and for opsonophagocytic activity (OPA), for induction of C3b deposition products, and for IgG binding with live B. pertussis as the antigen. We observed high correlations between OPA and IgG against live bacteria (r = 0.83), between OPA and IgG anti-FHA (r = 0.79), between OPA and anti-PT IgG (r = 0.68), and between OPA and C3b binding (r = 0.70) (P < 0.0001 for all). Anti-PT IgA did not correlate closely with the other assays.
引用
收藏
页码:855 / 862
页数:8
相关论文
共 45 条
  • [1] Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease
    Aase, A
    Næss, LM
    Sandin, RH
    Herstad, TK
    Oftung, F
    Holst, J
    Haugen, IL
    Hoiby, EA
    Michaelsen, TE
    [J]. VACCINE, 2003, 21 (17-18) : 2042 - 2051
  • [2] Aase A, 1998, SCAND J IMMUNOL, V47, P388
  • [3] CLONING, EXPRESSION, AND DNA-SEQUENCE ANALYSIS OF GENES ENCODING NONTYPABLE HAEMOPHILUS-INFLUENZAE HIGH-MOLECULAR-WEIGHT SURFACE-EXPOSED PROTEINS RELATED TO FILAMENTOUS HEMAGGLUTININ OF BORDETELLA-PERTUSSIS
    BARENKAMP, SJ
    LEININGER, E
    [J]. INFECTION AND IMMUNITY, 1992, 60 (04) : 1302 - 1313
  • [4] Activation of the complement cascade by Bordetella pertussis
    Barnes, MG
    Weiss, AA
    [J]. FEMS MICROBIOLOGY LETTERS, 2003, 220 (02) : 271 - 275
  • [5] Growth phase influences complement resistance of Bordetella pertussis
    Barnes, MG
    Weiss, AA
    [J]. INFECTION AND IMMUNITY, 2002, 70 (01) : 403 - 406
  • [6] Carlsson R. M., 1999, Clinical Microbiology and Infection, V5, P709, DOI 10.1111/j.1469-0691.1999.tb00520.x
  • [7] PHAGOCYTE IMPOTENCE CAUSED BY AN INVASIVE BACTERIAL ADENYLATE-CYCLASE
    CONFER, DL
    EATON, JW
    [J]. SCIENCE, 1982, 217 (4563) : 948 - 950
  • [8] Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis
    de Melker, HE
    Versteegh, FGA
    Conyn-van Spaendonck, MAE
    Elvers, LH
    Berbers, GAM
    van der Zee, A
    Schellekens, JFP
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) : 800 - 806
  • [9] A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine
    Gustafsson, L
    Hallander, HO
    Olin, P
    Reizenstein, E
    Storsaeter, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) : 349 - 355
  • [10] Serologic response and antibody-titer decay in adults with pertussis
    Heininger, U
    Cherry, JD
    Stehr, K
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (04) : 591 - 594